← 返回

DDOST 与宫颈癌肿瘤免疫抑制微环境相关

英文原题:DDOST is associated with tumor immunosuppressive microenvironment in cervical cancer.

查看英文原题

DDOST is associated with tumor immunosuppressive microenvironment in cervical cancer.

PubMed 2024/03/09(内容时间) Discov Oncol Q3 · IF 2.8(JCR 2025)

分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。

中文摘要

已有证据表明,DDOST 在癌症发生和进展中发挥重要作用。然而,尚无关于 DDOST 在宫颈肿瘤发生中功能的报道。因此,我们利用生物信息学技术研究了 DDOST 与预后、突变、启动子甲基化、免疫细胞浸润和药物敏感性的关系。我们的结果表明,DDOST 在多种肿瘤类型中显著上调,并与不良预后相关,包括宫颈癌。Cox 回归分析揭示,高 DDOST 表达与宫颈癌患者较差的生存相关。免疫浸润分析确定,DDOST 与 CD8 T 细胞和 NK 细胞呈负相关。引人注目的是,对多种药物的敏感性与 DDOST 的表达呈负相关。因此,我们的发现揭示,DDOST 可能在宫颈癌的肿瘤微环境和肿瘤免疫调节中发挥重要作用,这表明 DDOST 可能是一个有用的预后生物标志物和癌症治疗的潜在治疗靶点。

展开英文摘要原文

Evidence has revealed that DDOST plays an important role in cancer development and progression.

However, there are no reports on functions of DDOST in cervical tumorigenesis. Hence, we investigated the relationship of DDOST with prognosis, mutation, promoter methylation, immune cell infiltration, and drug sensitivity using bioinformatics techniques.

Our results demonstrated that DDOST was significantly upregulated in a variety of tumor types and correlated with poor prognosis, including cervical cancer. Cox regression analysis dissected that high DDOST expression was associated with poor survival in cervical cancer patients. Immune infiltration analysis defined that DDOST was negatively correlated with CD8 T cells and NK cells. Strikingly, the sensitivity to multiple drugs was negatively correlated with the expression of DDOST.

Therefore, our findings uncovered that DDOST could play an essential role in the tumor microenvironment and tumor immune regulation in cervical cancer, which indicated that DDOST could be a useful biomarker for prognosis and a potential therapeutic target for cancer treatment.

论文信息

作者
Mei J、Pan L、Huang M、Bao D、Gao H、Wang D
第一作者单位
Department of Obstetrics and Gynecology, The Second Affiliated Hospital of Wenzhou Medical University, Wenzhou, 325027, China.China
通讯作者单位
Department of Obstetrics and Gynecology, The Second Affiliated Hospital of Wenzhou Medical University, Wenzhou, 325027, China. 113112@wmu.edu.cn.China
期刊
Discover oncology2024 Mar 9
原文标识
PubMed 38460058 · DOI 10.1007/s12672-024-00927-z